-
Symbol
-
SYRS on OTC
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, $0.001 par value per share
-
Latest Disclosed Ownership
-
707K shares
-
Security Ownership
-
2.6%
Samsara BioCapital, L.P. ownership in Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (SYRS)
2025-03-27 - Samsara BioCapital, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 707K shares of Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (SYRS).
This represents 2.6% percent ownership of the company.